aetherAI vs Proscia
Two digital pathology platforms that host algorithms as well as building them, competing in different home markets. aetherAI comes from Taiwan with deployments across major Asian institutions, spans anatomical pathology and haematology rather than one tumour type, and secured both a United States clearance and European certification for its image management platform in 2026, which is a real move toward global reach. Proscia has the deeper Western installed base, serving clinical laboratories and life sciences customers on the same infrastructure. For a laboratory outside Asia, Proscia is the lower friction deployment with local support. aetherAI is the more interesting record because of the haematology reach, and its dual certification means it should now be on shortlists it would not have appeared on a year ago.
- It spans two distinct domains rather than one tumour type, covering anatomical pathology and haematology, with training scale disclosed for the haematology product.
- The image management platform secured both a United States clearance and European certification in 2026, which is a genuine dual market position rather than a single market one.
- The platform hosts diagnostic algorithms rather than only running its own, so a laboratory gets infrastructure and applications from one vendor.
- Its platform manages and analyses whole slide data for clinical laboratories and life sciences customers at established scale, which is a deeper installed base in Western markets.
- The clinical laboratory and life sciences split means the same infrastructure serves diagnostic work and research contracts, spreading the investment.
- For a laboratory in North America or Europe, an established platform with local support and regulatory standing is a lower risk deployment.
Side by Side
| Axis | A aetherAI |
P Proscia |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Digital Pathology AI page.
Read the regulatory footprint by market rather than by company, since both vendors hold different permissions in different jurisdictions and a product usable for diagnosis in one place may be research use only in another. aetherAI publishes no health privacy statement, business associate terms, hosting detail or subgroup analysis. Neither publishes pricing.
Staining and scanner variation between laboratories remains the largest uncontrolled variable for any algorithm hosted on either platform, and neither vendor imposes a published performance requirement on the third party algorithms it distributes.